The finding has implications for all of us, write Harvard physician-researchers Christopher Worsham and Anupam Jena.

The Alzheimer's Accountability and Investment Act (Public Law 118-93), enacted on October 1, 2024, mandates that the National ...

Monday through Friday, at the Warwick Mall, they walk. "This is a very popular place for walking," said Judy Enos, one of the ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

“There are things that we can do at all stages of our lives deliberately,” says Prof Schott. “It’s never too early to start ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

That estimate is based on a new study that found a higher lifetime risk than previously thought: After age 55, people have up ...

"Our study results forecast a dramatic rise in the burden from dementia in the United States over the coming decades, with ...

Biogen (BIIB) and Eisai's (ESALF) (ESAIY) announce that U.S. FDA agreed to review their subcutaneous form of Alzheimer's ...

As the American population ages, a new study finds the average lifetime risk of dementia for adults over 55 is around 42 ...

The Alzheimer’s Association encourages families to plan early and discuss among each other how to best take care of a loved ...